DrugPatentWatch Database Preview
Patent: RE48164
» See Plans and Pricing
Summary for Patent: RE48164
| Title: | Compounds and compositions for delivering active agents |
| Abstract: | The present invention provides delivery agent compounds, compositions containing delivery agent compounds and an active agent and methods for delivering active agents, such as biologically or chemically active agents. |
| Inventor(s): | Liao; Jun (Roseland, NJ), Tang; Pingwah (Roseland, NJ), Gschneidner; David (Roseland, NJ), Maeyer; Jonathan (Roseland, NJ) |
| Assignee: | EMISPHERE TECHNOLOGIES INC. (Roseland, NJ) |
| Application Number: | 15/355,634 |
| Patent Claims: | see list of patent claims |
Details for Patent RE48164
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | HUMULIN R | insulin recombinant human | INJECTABLE;INJECTION | 018780 | 001 | 1982-12-02 | Start Trial | EMISPHERE TECHNOLOGIES INC. (Roseland, NJ) | 2040-08-28 | RX | search | |
| Lilly | HUMULIN R KWIKPEN | insulin human | SOLUTION;SUBCUTANEOUS | 018780 | 002 | 1982-12-02 | Start Trial | EMISPHERE TECHNOLOGIES INC. (Roseland, NJ) | 2040-08-28 | RX | search | |
| Lilly | HUMULIN R | insulin human | SOLUTION;SUBCUTANEOUS | 018780 | 004 | 1982-12-02 | Start Trial | EMISPHERE TECHNOLOGIES INC. (Roseland, NJ) | 2040-08-28 | RX | search | |
| Lilly | HUMULIN R PEN | insulin recombinant human | INJECTABLE;INJECTION | 018780 | 005 | 1982-12-02 | Start Trial | EMISPHERE TECHNOLOGIES INC. (Roseland, NJ) | 2040-08-28 | RX | search | |
| Amgen | NEUPOGEN | filgrastim | VIAL | 103353 | 001 | 1991-02-20 | Start Trial | EMISPHERE TECHNOLOGIES INC. (Roseland, NJ) | 2040-08-28 | RX | search | |
| Amgen | NEUPOGEN | filgrastim | VIAL | 103353 | 002 | 1991-02-20 | Start Trial | EMISPHERE TECHNOLOGIES INC. (Roseland, NJ) | 2040-08-28 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent RE48164
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2662853 | Start Trial |
| European Patent Office | 2057112 | Start Trial |
| Japan | 2010502643 | Start Trial |
| Japan | 5577094 | Start Trial |
| United States of America | 2010015088 | Start Trial |
| United States of America | 8895777 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
